Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

July 22, 2017

Chicago, Illinois

Agenda

Saturday, July 22, 2017

Session I: Evolving Approaches to Current Clinical Challenges
Moderator: David T. Rubin, MD, FACG, AGAF

8:00 am

Welcome and pre-activity learner survey
David T. Rubin, MD, FACG, AGAF

8:10 am

What factors influence choice of first therapy in IBD: How can we predict response and be smarter?
Mark Osterman, MD

8:30 am

Understanding non-response and loss of response in IBD: Which is it and when do we change classes?
David T. Rubin, MD, FACG, AGAF

8:50 am

Therapeutic drug monitoring: Should we use it routinely or occasionally in IBD?
Adam S. Cheifetz, MD

9:10 am

Getting your patient on therapy: What resources are available and how can we do this better?
Mark Osterman, MD

9:30 am

Faculty discussion

10:00 am

Post-activity knowledge/competence assessment via ARS

10:10 am

Break

Session II: Emerging Therapies
Moderator: Russell Cohen, MD

10:40 am

Pre-activity knowledge/competence assessment via ARS
David T. Rubin, MD, FACG, AGAF

10:50 am

Role of emerging therapies in IBD: Where will they belong in our algorithms?
Dermot McGovern, MD, PhD

11:10 am

The emerging world of biosimilars: What do we know about interchangeability and extrapolation?
Russell Cohen, MD

11:30 am

State of art in diet and microbiome: Are we there yet?
James D. Lewis, MD, MSCE

11:50 am

Bench to bedside top 10: What did we learn about IBD research and upcoming therapies from DDW 2017?
Dermot McGovern, MD, PhD

12:10 pm

Faculty discussion

12:40 pm

Post-activity knowledge/competence assessment via ARS

1:00 pm

Lunch

Session III: Specific patient types
Moderator: David T. Rubin, MD, FACG, AGAF

2:15 pm

Pre-activity knowledge/competence assessment via ARS
David T. Rubin, MD, FACG, AGAF

2:25 pm

Management of joint pain in IBD (rheumatology)
Reem Jan, MBBS

2:45 pm

Management of rash in IBD (dermatology)
Michelle Weir, MD

3:05 pm

Faculty discussion

3:25 pm

Break

3:45 pm

Case discussion: Management of the complex pouch patient
Atsushi Sakuraba, MD, PhD

4:05 pm

Case discussion: Management of severe IBD non-responsive to TNF-inhibitor therapy
Russell Cohen, MD

4:25 pm

Case discussion: Management of the post-op patient with complications
Dermot McGovern, MD, PhD

4:45 pm

Final remarks, recap of key points, and post-activity knowledge/competence assessment via ARS

5:00 pm

Adjourn